SPY414.92-5.67 -1.35%
DIA332.96-5.20 -1.54%
IXIC14,030.38-130.97 -0.92%

BRIEF-Amicus Therapeutics Reports Q1 Loss Per Share Of $0.25

05/10/2021 07:53
BRIEF-Amicus Therapeutics Reports Q1 Loss Per Share Of $0.25

- Amicus Therapeutics Inc FOLD.O:

  • Q1 LOSS PER SHARE $0.25

  • SEES FY REVENUE $300 MILLION TO $315 MILLION

  • Q1 EARNINGS PER SHARE ESTIMATE $-0.24 -- REFINITIV IBES DATA

  • GLOBAL REVENUE FOR GALAFOLD IN Q1 OF 2021 WAS $66.4 MILLION

Source text for Eikon: ID:nGNXN28dz

Further company coverage: FOLD.O


(([email protected];))